366 related articles for article (PubMed ID: 23406994)
21. Effectiveness of megestrol acetate in patients with advanced cancer: a randomized, double-blind, crossover study.
Bruera E; Ernst S; Hagen N; Spachynski K; Belzile M; Hanson J; Summers N; Brown B; Dulude H; Gallant G
Cancer Prev Control; 1998 Apr; 2(2):74-8. PubMed ID: 9765767
[TBL] [Abstract][Full Text] [Related]
22. Randomized comparison of megestrol acetate versus dexamethasone versus fluoxymesterone for the treatment of cancer anorexia/cachexia.
Loprinzi CL; Kugler JW; Sloan JA; Mailliard JA; Krook JE; Wilwerding MB; Rowland KM; Camoriano JK; Novotny PJ; Christensen BJ
J Clin Oncol; 1999 Oct; 17(10):3299-306. PubMed ID: 10506633
[TBL] [Abstract][Full Text] [Related]
23. Mirtazapine versus megestrol acetate in treatment of anorexia-cachexia in advanced cancer patients: a randomized, double-blind trial.
Chowdhury IH; Rahman MS; Chowdhury MNK; Afroze YJ; Tabassum M; Marnush M; Zerin N
Jpn J Clin Oncol; 2024 May; 54(5):530-536. PubMed ID: 38323684
[TBL] [Abstract][Full Text] [Related]
24. Thalidomide in the treatment of cancer cachexia: a randomised placebo controlled trial.
Gordon JN; Trebble TM; Ellis RD; Duncan HD; Johns T; Goggin PM
Gut; 2005 Apr; 54(4):540-5. PubMed ID: 15753541
[TBL] [Abstract][Full Text] [Related]
25. The effect of megestrol acetate on anorexia, weight loss and cachexia in cancer and AIDS patients (review).
Strang P
Anticancer Res; 1997; 17(1B):657-62. PubMed ID: 9066597
[TBL] [Abstract][Full Text] [Related]
26. Effects of megestrol acetate in patients with cancer anorexia-cachexia syndrome--a systematic review and meta-analysis.
Leśniak W; Bała M; Jaeschke R; Krzakowski M
Pol Arch Med Wewn; 2008 Nov; 118(11):636-44. PubMed ID: 19140567
[TBL] [Abstract][Full Text] [Related]
27. [New strategies for tumor-related cachexia].
HNO; 1997 Nov; 45(11 Suppl):1-8. PubMed ID: 9509016
[No Abstract] [Full Text] [Related]
28. A retrospective study of the association between megestrol acetate administration and mortality among nursing home residents with clinically significant weight loss.
Bodenner D; Spencer T; Riggs AT; Redman C; Strunk B; Hughes T
Am J Geriatr Pharmacother; 2007 Jun; 5(2):137-46. PubMed ID: 17719516
[TBL] [Abstract][Full Text] [Related]
29. Megestrol acetate for cachexia-anorexia syndrome. A systematic review.
Ruiz-García V; López-Briz E; Carbonell-Sanchis R; Bort-Martí S; Gonzálvez-Perales JL
J Cachexia Sarcopenia Muscle; 2018 Jun; 9(3):444-452. PubMed ID: 29542279
[TBL] [Abstract][Full Text] [Related]
30. Phase I/II trial of formoterol fumarate combined with megestrol acetate in cachectic patients with advanced malignancy.
Greig CA; Johns N; Gray C; MacDonald A; Stephens NA; Skipworth RJ; Fallon M; Wall L; Fox GM; Fearon KC
Support Care Cancer; 2014 May; 22(5):1269-75. PubMed ID: 24389826
[TBL] [Abstract][Full Text] [Related]
31. The effect of cyproheptadine hydrochloride (periactin) and megestrol acetate (megace) on weight in children with cancer/treatment-related cachexia.
Couluris M; Mayer JL; Freyer DR; Sandler E; Xu P; Krischer JP
J Pediatr Hematol Oncol; 2008 Nov; 30(11):791-7. PubMed ID: 18989154
[TBL] [Abstract][Full Text] [Related]
32. Pharmacological treatment of cachexia: any progress?
Bruera E
Support Care Cancer; 1998 Mar; 6(2):109-13. PubMed ID: 9540168
[TBL] [Abstract][Full Text] [Related]
33. Dronabinol versus megestrol acetate versus combination therapy for cancer-associated anorexia: a North Central Cancer Treatment Group study.
Jatoi A; Windschitl HE; Loprinzi CL; Sloan JA; Dakhil SR; Mailliard JA; Pundaleeka S; Kardinal CG; Fitch TR; Krook JE; Novotny PJ; Christensen B
J Clin Oncol; 2002 Jan; 20(2):567-73. PubMed ID: 11786587
[TBL] [Abstract][Full Text] [Related]
34. A prospective randomized study of megestrol acetate and ibuprofen in gastrointestinal cancer patients with weight loss.
McMillan DC; Wigmore SJ; Fearon KC; O'Gorman P; Wright CE; McArdle CS
Br J Cancer; 1999 Feb; 79(3-4):495-500. PubMed ID: 10027319
[TBL] [Abstract][Full Text] [Related]
35. Quality of life and stimulation of weight gain after treatment with megestrol acetate: correlation between cytokine levels and nutritional status, appetite in geriatric patients with wasting syndrome.
Yeh S; Wu SY; Levine DM; Parker TS; Olson JS; Stevens MR; Schuster MW
J Nutr Health Aging; 2000; 4(4):246-51. PubMed ID: 11115810
[TBL] [Abstract][Full Text] [Related]
36. Comparison of three different treatment modalities in the management of cancer cachexia.
Kanat O; Cubukcu E; Avci N; Budak F; Ercan I; Canhoroz M; Olmez F
Tumori; 2013; 99(2):229-33. PubMed ID: 23748819
[TBL] [Abstract][Full Text] [Related]
37. Treatment of the cancer anorexia-cachexia syndrome: a critical reappraisal.
Lelli G; Montanari M; Gilli G; Scapoli D; Antonietti C; Scapoli D
J Chemother; 2003 Jun; 15(3):220-5. PubMed ID: 12868546
[TBL] [Abstract][Full Text] [Related]
38. Treating malnutrition with megestrol acetate: literature review and review of our experience.
Karcic E; Philpot C; Morley JE
J Nutr Health Aging; 2002 May; 6(3):191-200. PubMed ID: 12152625
[TBL] [Abstract][Full Text] [Related]
39. Anamorelin for patients with cancer cachexia: an integrated analysis of two phase 2, randomised, placebo-controlled, double-blind trials.
Garcia JM; Boccia RV; Graham CD; Yan Y; Duus EM; Allen S; Friend J
Lancet Oncol; 2015 Jan; 16(1):108-16. PubMed ID: 25524795
[TBL] [Abstract][Full Text] [Related]
40. [Current views on use of megestrol acetate in oncology practice].
Vyzula R
Vnitr Lek; 1997 Apr; 43(4):250-5. PubMed ID: 9601846
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
